Asymptomatic ("silent") ischaemia has been shown to be of prognostic significance in patients with stable and unstable angina and more recently in patients recovering after myocardial infarction. No therapeutic regimen has yet been shown to improve the prognosis of patients with silent ischaemia after infarction, which can be found in as many as a third of these patients. Attempts to achieve therapeutic revascularisation in all these patients may be undesirable, but early revascularisation could be especially beneficial in some selected high risk patients. Two hundred and fifty consecutive clinically stable survivors of myocardial infarction who had predischarge submaximal exercise tests were followed up for a year. Silent ischaemia was found in 27% of these patients; 15% had symptomatic ischaemia. Patients with a positive exercise test were prescribed a ,B blocker before discharge. Mortality in patients with silent (9A4%) and symptomatic (54%) ischaemia in the first year after infarction was not significantly different. Patients with symptomatic ischaemia were more likely to have undergone coronary artery bypass grafting in the first year. Patients with silent ischaemia were, however, significantly more likely to die than patients with a negative exercise test (relative odds 12:1). Patients with silent ischaemia and an abnormal blood pressure response or who could not complete a submaximal exercise protocol were at particularly high risk, being 32 times more likely to die than those with a negative test (95% confidence interval from 3-3 to 307 times more likely). First year mortality in this group was 22%. The benefits of therapeutic revascularisation in this high risk group need to be studied.
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Patients with symptomatic ischaemia were more likely to have undergone coronary artery bypass grafting in the first year. Patients with silent ischaemia were, however, significantly more likely to die than patients with a negative exercise test (relative odds 12:1). Patients with silent ischaemia and an abnormal blood pressure response or who could not complete a submaximal exercise protocol were at particularly high risk, being 32 times more likely to die than those with a negative test (95% confidence interval from 3-3 to 307 times more likely). First year mortality in this group was 22%. The benefits of therapeutic revascularisation in this high risk group need to be studied.
Silent ischaemia has been recognised since early this century ("angina sine dolore" Six patients with silent ischaemia died-three suddenly, one after further myocardial infarction, and one in intractable heart failure; the circumstances surrounding the death of the sixth patient were not known ( Mets, metabolic equivalents. nosis after infarction3' and were not prescribed if there were contraindications. Mortality in patients with silent ischaemia (9 4%) and symptomatic ischaemia (5A4%) was not significantly different. Those with symptomatic ischaemia were more likely to undergo coronary artery bypass grafting-probably because they were more likely to have angina in the year after infarction. None of the patients undergoing operation died within the first year. Although it has never been formally tested in post-infarct patients, careful selection of patients for early revascularisation is likely to improve prognosis. 32 Our results indicate that the absence of symptoms associated with silent ischaemia should not necessarily preclude patients from a revascularisation programme. Attempted revascularisation ofall patients with silent ischaemia after infarction is, however, probably not desirable.""35 A group of patients with silent ischaemia who were at particularly high risk was identified by ST segment depression during exercise accompanied by an abnormal blood pressure response or by the patient's inability to complete the submaximal exercise protocol. Mortality was 22% in this group. Although by no means forming a comparable group, the patients receiving placebo in the Coronary Drug Project (men who had survived to at least three months after infarction) had a first year mortality of about 5% . Only those in the top three deciles of risk (based on 10 clinical characteristics) had afiveyear mortality greater than 22%.36 The benefit of therapeutic revascularisation in these patients should be studied in a much larger population. Our findings suggest that objective evidence of ischaemia after infarction should lead to further stratification and not simply be considered as a concept to "excite and reward underemployed cardiologists".3
The coronary arteriographic characteristics of the groups with silent ischaemia and symptomatic ischaemia were similar-indicating that symptoms are not caused by more widespread coronary disease, and confirming similar observations made by others.243839 The extent of left ventricular damage was also similar in the two groups and this factor does not account for the different mortalities. In the Coronary Artery Surgery Study, although patients with both angina and ST depression were somewhat more likely to have triple vessel disease than those with only one of these features, the long term outcome was similar in these three groups; outcome in each group was related to the number of diseased vessels. 24 There are, however, major population differences between such a study and the present one in which only post-infarction patients were investigated.
No features of the previous clinical history helped to distinguish between those with silent ischaemia and those with symptomatic ischaemia. Patients with silent ischaemia, were, however, more likely to have a history of hypertension than patients with a negative exercise test. This difference may be partly explained by a higher incidence of abnormalities on the resting electrocardiogram in patients with a history of hypertension. In such patients further significant ST segment depression on exercise may simply represent an exercise induced exaggeration of an abnormality that is already present. Alternatively, these changes may indicate true ischaemia, reflecting patterns of coronary disease of small vessels or increased oxygen demands in hypertensive patients. An association between hypertension and the development of silent myocardial infarction has been noted before.'0 "4 The group with silent ischaemia had a higher incidence of inferior infarction than either the symptomatic group or those with a negative exercise test. Since the 12 lead electrocardiographic exercise test is more sensitive for anterior than inferior ST segment depression,38 it may be that some patients with anterior infarcts but with residual inferior ischaemia are "missed" by the exercise test when ST segment depression is the only feature considered. Patients with symptomatic ischaemia were more likely to have had a non-Q wave infarction than those with silent ischaemia (relative odds 2-5:1) and patients with negative exercise tests were the least likely to have had a non-Q wave infarction.
There are particular difficulties in defining "ischaemia" on the exercise electrocardiogram soon after infarction. ST segment elevation in the territory of the infarct may become more pronounced on exercise, and if ST segment depression occurs in the electrocardiographic leads that represent the area opposite to this territory, it is impossible to be certain whether this is a reciprocal electrical event or represents true ischaemia. This is potentially important in the context ofthis study because the group with ST segment elevation might have a higher mortality related to more extensive left ventricular damage. Further analysis, however, showed that mortality was the same whether ST depression occurred alone or together with ST elevation. In addition, it might be argued that patients in whom dyspnoea develops in the presence of ST depression do not have "silent" ischaemia. But there are difficulties in objectively assessing the cause of dyspnoea in patients soon after infarction, and there are advantages in a simple definition of silent ischaemia that allows for comparison between studies.
Exercise testing after myocardial infarction is now recognised as a powerful means of risk stratification; it provides multiple variables some of which are more useful for predicting clinical outcome than others. '6 We found that those with ST depression, whether silent or not, have a higher mortality than those with a negative exercise test. Those patients in whom silent ischaemia is associated with an abnormal blood pressure response or who are unable to complete a submaximal protocol are at particular risk. Patients with symptoms of angina associated with the ST depression are currently more likely to undergo attempted revascularisation than those with silent ischaemia. Our results suggest that withholding therapeutic revascularisation from those with silent ischaemia, particularly the subgroups at higher
